Duncker Streett & Co’s Bausch Health BHC Stock Holding History

Duncker Streett & Co’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-400	Closed	-$6K	–	519
2020 Q1	$6K	Hold	400	–	–	﹤0.01%	466
2019 Q4	$12K	Buy	+400	New	+$10.4K	﹤0.01%	455
2019 Q3	–	Sell	-400	Closed	-$10K	–	283
2019 Q2	$10K	Sell	400 -200	-33%	-$4.75K	﹤0.01%	488
2019 Q1	$15K	Hold	600	–	–	﹤0.01%	471
2018 Q4	$11K	Hold	600	–	–	﹤0.01%	483
2018 Q3	$15K	Buy	600 +400	+200%	+$9.16K	﹤0.01%	482
2018 Q2	$5K	Hold	200	–	–	﹤0.01%	545
2018 Q1	$3K	Hold	200	–	–	﹤0.01%	566
2017 Q4	$4K	Hold	200	–	–	﹤0.01%	554
2017 Q3	$3K	Hold	200	–	–	﹤0.01%	575
2017 Q2	$3K	Hold	200	–	–	﹤0.01%	582
2017 Q1	$2K	Hold	200	–	–	﹤0.01%	602
2016 Q4	$3K	Hold	200	–	–	﹤0.01%	582
2016 Q3	$5K	Hold	200	–	–	﹤0.01%	556
2016 Q2	$4K	Hold	200	–	–	﹤0.01%	557
2016 Q1	$5K	Buy	+200	New	+$14.8K	﹤0.01%	551
2014 Q1	–	Sell	-100	Closed	-$12K	–	573
2013 Q4	$12K	Sell	100 -200	-67%	-$21.9K	﹤0.01%	469
2013 Q3	$31K	Hold	300	–	–	0.01%	388
2013 Q2	$26K	Buy	+300	New	+$23.6K	0.01%	399

Other funds holding BHC

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

GAM

Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

Duncker Streett & Co's BHC Position: Q2 2020 in Review

Duncker Streett & Co sold out of Bausch Health (BHC) in Q2 2020, closing a stake of 400 shares — an estimated $6K sold.

Duncker Streett & Co first reported a position in BHC in Q2 2013 and held it in 19 quarters. The position peaked at $31K in Q3 2013. 303 funds tracked by Wall St. Rank hold BHC as of Q2 2020.

Duncker Streett & Co reported no remaining Bausch Health position as of Q2 2020 after selling out during the quarter.
Duncker Streett & Co sold 400 Bausch Health shares in Q2 2020, an estimated $6K.
Duncker Streett & Co first reported a position in Bausch Health in Q2 2013 and held it in 19 quarters.
Duncker Streett & Co's Bausch Health position peaked at $31K in Q3 2013.
303 funds tracked by Wall St. Rank held Bausch Health as of Q2 2020.

Based on Duncker Streett & Co's 13F filing for Q2 2020, filed 22 Jul 2020.